Citalopram study shows no autism benefits
WSJ
Email successfully sent
close windowA study, published June 1, 2009 in the Archives of General Psychiatry, showed that the popularly prescribed antidepressant, citalopram, did not “reduce repetitive behaviors that are a key characteristic of autism and are a significant reason why this class of antidepressants is prescribed.”
For full report, read the full article published in the Wall Street Journal.
Nationwide research finds that citalopram is no more effective than a placebo and that its side effects are twice as bad. About a third of autistic kids take the drug, known as Celexa in the U.S.
For full report, read the full article published in the Los Angeles Times
Related Articles
Multi-year divide between possible and actual autism diagnoses
A key success factor for helping those with autism better cope and interact in the world is early identificati ..
Brain imaging finds neurological markers for autism
A recent study conduced by the Kennedy Krieger Institute, and published in the April 23 issue of Brain Advance ..
Research on fever and autism
Two doctors from Albert Einstein College of Medicine of Yeshiva University have published a study, published i ..
